MedPath

A randomized controlled trial on the effectiveness of prophylactic antibiotics compared to standard therapy on prevention of feto maternal and neonatal infections.

Phase 3
Conditions
Prelabour rupture of membrane(PROM)
Registration Number
SLCTR/2019/033
Lead Sponsor
Professorial unit- Obstetics & Gynaecology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

1.Women with PROM > 37 weeks and < 41 weeks of gestational age
2. Women with singleton fetus with cephalic presentation
3. Women with no uterine contraction on admission
4. Women with ruptured membrane less than 12 hours

Exclusion Criteria

1.Contraindication for normal vaginal delivery
2.Planned EL/LSCS or indication for EM/ LSCS on admission
3.Death in utero or fetal anomaly
4.Contraindication for oxytocin or prostaglandins
5.Allergic to erythromycin
6. Presence of an indication to start Group B Streptococcal antibiotic prophylaxis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath